# AdaptHealth Corp.: filings

AHCO · Nasdaq · CIK 1725255 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ahco.md) · [Financials](/companies/ahco/financials.md) · [Filings](/companies/ahco/filings.md) · [Insiders](/companies/ahco/insiders.md)

## Reports and events: 206 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 289, 8-K 112, 3 42, 424B3 32, 10-Q 26, SC 13D/A 26, 144 24, UPLOAD 18, CORRESP 17, 4/A 13, SC 13G/A 13, SC 13D 10, DEFA14A 9, 10-K 8, DEF 14A 8, SC 13G 8, SCHEDULE 13G/A 8, PRER14A 7, EFFECT 6, S-1/A 6, S-8 6, 8-K/A 4, ARS 4, SCHEDULE 13G 4, 424B4 3, PRE 14A 3, S-1 3, S-3 3, 10-K/A 2, 25-NSE 2, 424B5 2, 5 2, 8-A12B 1, CERT 1, DEFM14A 1, DEFR14A 1, DRS 1, PREM14A 1, S-1MEF 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-08 | 20:16 ET | [8-K](/filings/0001104659-26-105912.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-105912 |
| 2026-08-04 | 20:36 ET | [10-Q](/filings/0001628280-26-052646.md) | Quarterly report, period 2026-06-30 | 0001628280-26-052646 |
| 2026-08-04 | 11:09 ET | [8-K](/filings/0001628280-26-052149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-052149 |
| 2026-07-20 | 20:35 ET | [8-K](/filings/0001104659-26-085086.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-085086 |
| 2026-07-07 | 20:45 ET | [8-K](/filings/0001104659-26-081305.md) | 7.01 Regulation FD disclosure | 0001104659-26-081305 |
| 2026-07-02 | 20:01 ET | [8-K](/filings/0001104659-26-080297.md) | 1.05 Material cybersecurity incident | 0001104659-26-080297 |
| 2026-06-22 | 20:16 ET | [8-K](/filings/0001104659-26-076390.md) | 5.07 Shareholder vote results | 0001104659-26-076390 |
| 2026-06-02 | 01:02 ET | [8-K/A](/filings/0001104659-26-069119.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-069119 |
| 2026-05-05 | 20:21 ET | [10-Q](/filings/0001628280-26-030602.md) | Quarterly report, period 2026-03-31 | 0001628280-26-030602 |
| 2026-05-05 | 11:07 ET | [8-K](/filings/0001628280-26-030120.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-030120 |
| 2026-04-28 | 20:33 ET | [DEF 14A](/filings/0001628280-26-027965.md) | Proxy statement, period 2026-06-18 | 0001628280-26-027965 |
| 2026-04-13 | 12:11 ET | [8-K](/filings/0001628280-26-024835.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-024835 |
| 2026-03-12 | 01:10 ET | [SCHEDULE 13D/A](/filings/0001193125-26-104757.md) | Ownership report, active investor, amended | 0001193125-26-104757 |
| 2026-02-24 | 22:09 ET | [10-K](/filings/0001628280-26-011213.md) | Annual report, period 2025-12-31 | 0001628280-26-011213 |
| 2026-02-24 | 12:11 ET | [8-K](/filings/0001628280-26-010872.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-010872 |
| 2025-11-04 | 21:55 ET | [10-Q](/filings/0001628280-25-048944.md) | Quarterly report, period 2025-09-30 | 0001628280-25-048944 |
| 2025-11-04 | 12:06 ET | [8-K](/filings/0001628280-25-048527.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-048527 |
| 2025-08-05 | 21:09 ET | [10-Q](/filings/0001628280-25-037931.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037931 |
| 2025-08-05 | 11:11 ET | [8-K](/filings/0001628280-25-037598.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-037598 |
| 2025-08-05 | 11:08 ET | [8-K](/filings/0001104659-25-073912.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-073912 |
| 2025-06-30 | 20:25 ET | [8-K](/filings/0001104659-25-064140.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-064140 |
| 2025-06-20 | 21:23 ET | [10-K/A](/filings/0001628280-25-032464.md) | Annual report, amended, period 2024-12-31 | 0001628280-25-032464 |
| 2025-06-20 | 20:18 ET | [8-K](/filings/0001104659-25-061172.md) | 5.07 Shareholder vote results | 0001104659-25-061172 |
| 2025-05-06 | 20:29 ET | [10-Q](/filings/0001628280-25-022716.md) | Quarterly report, period 2025-03-31 | 0001628280-25-022716 |
| 2025-05-06 | 11:07 ET | [8-K](/filings/0001628280-25-022394.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022394 |
| 2025-04-30 | 15:55 ET | [DEF 14A](/filings/0001628280-25-020890.md) | Proxy statement, period 2025-06-18 | 0001628280-25-020890 |
| 2025-02-25 | 21:28 ET | [10-K](/filings/0001628280-25-007740.md) | Annual report, period 2024-12-31 | 0001628280-25-007740 |
| 2025-02-25 | 12:11 ET | [8-K](/filings/0001628280-25-007553.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-007553 |
| 2024-12-13 | 16:07 ET | [8-K](/filings/0001104659-24-128292.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-128292 |
| 2024-11-05 | 22:19 ET | [10-Q](/filings/0001628280-24-045365.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045365 |
| 2024-11-05 | 12:36 ET | [8-K](/filings/0001628280-24-045113.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045113 |
| 2024-10-30 | 21:22 ET | [8-K](/filings/0001104659-24-112672.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-112672 |
| 2024-10-22 | 10:01 ET | [8-K](/filings/0001104659-24-110349.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-110349 |
| 2024-09-30 | 20:15 ET | [8-K](/filings/0001104659-24-104290.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-104290 |
| 2024-09-16 | 12:39 ET | [8-K](/filings/0001104659-24-100033.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-100033 |
| 2024-08-26 | 11:30 ET | [8-K](/filings/0001104659-24-092623.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-092623 |
| 2024-08-19 | 21:03 ET | [8-K](/filings/0001104659-24-090892.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-090892 |
| 2024-08-06 | 20:30 ET | [10-Q](/filings/0001628280-24-035235.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035235 |
| 2024-08-06 | 11:01 ET | [8-K](/filings/0001628280-24-034954.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-034954 |
| 2024-07-03 | 13:19 ET | [8-K](/filings/0001104659-24-077607.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-077607 |
| 2024-06-21 | 20:37 ET | [8-K](/filings/0001104659-24-073974.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001104659-24-073974 |
| 2024-06-11 | 20:14 ET | [SC 13D/A](/filings/0001062993-24-012367.md) | Ownership report, active investor, amended | 0001062993-24-012367 |
| 2024-05-07 | 21:23 ET | [10-Q](/filings/0001628280-24-021191.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021191 |
| 2024-05-07 | 11:09 ET | [8-K](/filings/0001628280-24-020835.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-020835 |
| 2024-04-26 | 20:31 ET | [DEF 14A](/filings/0001104659-24-052998.md) | Proxy statement, period 2024-06-20 | 0001104659-24-052998 |
| 2024-04-17 | 20:20 ET | [8-K](/filings/0001104659-24-048318.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-048318 |
| 2024-03-04 | 21:33 ET | [8-K](/filings/0001104659-24-030510.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-030510 |
| 2024-02-27 | 21:33 ET | [10-K](/filings/0001628280-24-007254.md) | Annual report, period 2023-12-31 | 0001628280-24-007254 |
| 2024-02-27 | 12:18 ET | [8-K](/filings/0001628280-24-007032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-007032 |
| 2023-12-27 | 21:12 ET | [8-K](/filings/0001104659-23-129725.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-129725 |

Page 1 of 5. [Older](/companies/ahco/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.